Form 4: UnitedHealth Group Director Paul R. Garcia Reports Stock Transactions

Director Paul R. Garcia of UnitedHealth Group reported the acquisition of 6 shares of common stock and adjustments to holdings in various trusts.

Summary

• Paul R. Garcia, a director at UnitedHealth Group, reported a transaction involving the company's common stock.
• On December 17, 2024, Mr. Garcia acquired 6 shares of common stock as dividend equivalents.
• These dividend equivalents were paid on vested deferred stock units and are immediately vested.
• Following the transaction, Mr. Garcia's direct holdings decreased by 2,122 shares, while his indirect holdings through various trusts were adjusted.
• The report also details Mr. Garcia's holdings in revocable trusts and other trusts.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing detailing a standard transaction. It is neither positive nor negative, but rather a neutral disclosure of information.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It provides transparency into the stock ownership of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The reporting of dividend equivalents and trust holdings is typical for directors' stock transactions.
• Other companies such as CVS Health, Cigna, and Humana also have similar filings when their directors trade company stock.

Stakeholder Impact

• This filing provides transparency to shareholders regarding the stock transactions of a company director.
• The transaction is not expected to have a significant impact on other stakeholders.

Key Dates

Keywords

UnitedHealth Group, UNH, Paul R. Garcia, Director, Stock Transaction, Dividend Equivalents, Beneficial Ownership, Form 4, Deferred Stock Units, Trusts